The TWEAK/Fn14 pathway is involved in the modulation of inflammation in several chronic AD, including multiple sclerosis, SLE, rheumatoid arthritis, or ulcerative colitis (17). This evidence concerns the gene TNFSF12 and rheumatoid arthritis.